非内分泌科住院糖尿病会诊病例的临床特点及用药分析

doi:10.3969/j.issn.1671-7171.2023.05.007

Abstract
Figure/Table
References (0)
Related Citation (15)

Download: PDF (1135 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract 【Objective】To summarize and analyze the clinical characteristics and medication of inpatients with diabetes in non-endocrinology department of our hospital. 【Methods】The data of inpatient diabetes cases consulted by endocrinology department from July 2020 to December 2020 in our hospital were statistically analyzed. 【Results】A total of 702 cases of consultation in the study included 139 cases from surgical departments and 563 cases from non-surgical departments. The department with the largest consultation volume was cardiology department. Among the consultation patients,86 cases underwent surgical operation,57 cases underwent angiography and 67 cases underwent interventional operation,115 cases were infected and treated with intravenous antibiotics,25 cases were treated with glucocorticoids. There were 24 cases with hepatic insufficiency,54 cases with renal insufficiency,37 cases with hypertriglyceridemia,and 21 cases with hypoglycemia. After consultation,303 cases were treated with oral hypoglycemic drugs alone,163 cases with insulin alone and 181 cases with oral hypoglycemic drugs combined with insulin,and 55 cases had no hypoglycemic program after consultation (only diet and exercise education). The proportion of oral hypoglycemic drugs used alone in non-surgical departments was higher than that in surgical departments (P<0.05),and the proportion of insulin used alone in surgical departments was higher than that in non-surgical departments (P<0.05). After consultation,the combination of two drugs was the most common used in oral hypoglycemic drugs,and the usage of metformin was the highest among drug types. The intensive regimen was the most used in insulin hypoglycemic programs,and the usage rate of basal insulin was the highest among insulin types.【Conclusion】Diabetic consultation patients were mainly treated with oral hypoglycemic drugs in non-surgical departments,while insulin treated was mainly used in surgical departments. The emphasis of hypoglycemic drugs selection was different in different departments due to patients in different departments were with special conditions. In-depth understanding of the diagnosis and treatment characteristics of diabetes consultation patients is of great significance to improve the diagnosis and treatment level of diabetes in general hospitals.

Key words： Diabetes Mellitus Inpatients Prescription Drugs

Received: 01 August 2022

PACS:

R587.1

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors

Cite this article:

URL:

http://journal07.magtech.org.cn/yxlcyj/EN/10.3969/j.issn.1671-7171.2023.05.007 OR http://journal07.magtech.org.cn/yxlcyj/EN/Y2023/V40/I5/664

[1] 王薇,杨艳. 非内分泌科住院高血糖的管理现状[J].实用医院临床杂志,2021,18(1):185-187.
[2] 谭惠文. 四川大学华西医院内分泌代谢科总住院医师会诊工作情况分析[J].华西医学,2017,32(8):1277-1280.
[3] 中国住院患者血糖管理专家组中国医师协会内分泌代谢科医师分会. 中国住院患者血糖管理专家共识[J].中华内分泌代谢杂志,2017,33(1):1-10.
[4] OLARIU E,POOLEY N,DANEL A,et al. A systematic scoping review on the consequences of stress-related hyperglycaemia[J].PLoS One,2018,13(4):e194952.
[5] 陈娟,王钰,李丹斌. 糖尿病患者血糖控制水平与心电图异常的相关性分析[J].医学临床研究,2021,38(6):926-928.
[6] 李国锋,魏玉清,贾亮,等. 脑梗死合并代谢综合征与单纯脑梗死临床特点、近远期预后及相关影响因素比较[J].医学临床研究,2019,36(9):1697-1699.
[7] 王津京. 优化围手术期血糖管理规范化研究[D]. 北京:中国人民解放军医学院,2017.
[8] 谷秀莲,窦京涛,谷伟军,等. 综合性医院非内分泌专科住院糖尿病患者降糖治疗方式的调查[J].中华糖尿病杂志,2017,9(10):644-648.
[9] 吴远,田浩明. 中国成人住院患者围手术期的血糖管理[J].中华内科杂志,2017,56(3):213-215.
[10] GRANT B,CHOWDHURY T A. New guidance on the perioperative management of diabetes[J].Clin Med (Lond),2022,22(1):41-44.
[11] 二甲双胍临床应用专家共识(2018年版)[J].中国糖尿病杂志,2019,27(3):161-173.
[12] JOHNS E C,REYNOLDS R M. Topical glucocorticoids and risk of type 2 diabetes mellitus[J].Nat Rev Endocrinol,2019,15(7):379-380.
[13] 叶红英,李益明. 糖皮质激素对血糖的影响及其处理[J].中华糖尿病杂志,2021,13(1):1-4.
[14] SHAH P,KALRA S,YADAV Y,et al. Management of Glucocorticoid-Induced Hyperglycemia[J].Diabetes Metab Syndr Obes,2022,15:1577-1588.
[15] 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版)[J].中华糖尿病杂志,2021,13(4):311-398.
[16] 中国医师协会内分泌代谢科医师分会. DPP-4抑制剂临床应用专家共识[J].中华内分泌代谢杂志,2018,34(11):899-903.
[17] 中华医学会肾脏病学分会专家组. 糖尿病肾脏疾病临床诊疗中国指南[J].中华肾脏病杂志,2021,37(3):255-304.